[Analysis on prognostic factors of liver failure in children]

Shi-shu Zhu1, Hong-fei Zhang, Ju-mei Chen

  • 1Department of Pediatric Liver Diseases, The No 302 Hospital of The People's Liberation Army, Beijing, China.

Insights

Pediatric liver failure has a high mortality rate. Prothrombin activity (PTA) and total bilirubin (TBIL) levels are key indicators for improving survival rates in children with liver failure.

Area of Science:

  • Pediatric Hepatology
  • Clinical Medicine
  • Biochemistry

Context:

  • Liver failure in children presents a significant clinical challenge.
  • Retrospective analysis of 105 pediatric cases over 17 years.
  • High mortality rate underscores the need for prognostic indicators.

Purpose:

  • To identify prognostic factors influencing mortality in pediatric liver failure.
  • To analyze clinical and biochemical markers associated with survival.
  • To determine independent risk factors for poor outcomes.

Summary:

  • Mortality rate for pediatric liver failure was 68.6% in the studied cohort.
  • Univariate analysis identified age, clinical stage, prothrombin activity (PTA), albumin (AIB), total bilirubin (TBIL), and hepatic encephalopathy as significant factors.
  • Multivariate analysis revealed PTA and TBIL as independent predictors of mortality.

Impact:

  • Findings highlight the critical role of PTA and TBIL in assessing prognosis.
  • Early identification of these markers can guide timely diagnosis and treatment.
  • Improved management strategies based on these indicators may enhance survival rates in pediatric liver failure.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...